News Releases

2003 Archive

November 6, 2003 Generic Industry Welcomes Introduction of Access to Generic Medicines Bill Details of full legal and regulatory package will determine practical effect
The Canadian Generic Pharmaceutical Association (CGPA) today welcomed the federal government's first steps to allow its member companies to provide low-cost, Canadian-made generic pharmaceuticals to developing countries in times of health crises. | read more...
November 4, 2003 Generics Table Five-Point Plan for Drug-Cost Savings
Canadian generic drug makers today unveiled a five-point plan to save Canada's health-care system hundreds of millions of dollars annually in the cost of prescription medicines. | read more...
October 1, 2003 CGPA Statement Regarding the Government of Canada Initiative to Allow the Export of Canadian-made Generic Medicines to Developing Countries in Health Crises
The Canadian Generic Pharmaceutical Association (CGPA) is very pleased that the Government of Canada is responding to the request of the CGPA and many other organizations and individuals to allow Canadian generic pharmaceutical manufacturers to participate in the World Trade Organization’s landmark agreement to allow developing countries to import lower-cost generic pharmaceutical products to help combat health emergencies, such as the HIV/AIDS pandemic in sub-Saharan Africa. | read more...
July 30, 2003 Canada must support developing countries’ access to affordable medicines: through Doha and domestic laws by Jim Keon
In the summer of 2000, Canadian generic pharmaceutical manufacturer Apotex offered to provide HIV/AIDS drugs to developing countries in sub-Saharan Africa at cost. Ultimately, it did not. | read more...
June 16, 2003 President Bush ends abuse of automatic injunction under U.S. drug patent law. Now it’s Canada’s turn, says CGPA U.S. making major changes to special rules that automatically block generic competitors
It’s time for Canada to join United States President George Bush in stopping brand-name drug companies’ abuse of automatic injunctions against lower-cost generic drugs, Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) said today. | read more...
June 11, 2003 INCREASED USE OF GENERICS WOULD RESULT IN IMPORTANT SAVINGS BOTH FOR USERS AND GOVERNMENT
Reacting to another announced hike in premiums and deductibles in the provincial government’s prescription drug plan, the Canadian Generic Pharmaceutical Association (CGPA), which represents Canadian and Quebec manufacturers of generic drugs, would remind one and all that the Government of Quebec and users are forsaking $25 million in savings each year because of regulations that favour brand-name drugs. | read more...
June 3, 2003 Generics to Parliamentary Committee: End Abuse of Drug Patent Regulations Generic industry supports 20-year patents but regulations that automatically block generic competitors must go
Canadian generic drug makers today urged a Parliamentary committee to recommend that the federal government eliminate regulations of Canada’s Patent Act that have been systematically abused by brand-name drug companies. This abuse keeps lower-cost versions of prescription drugs off the market, adding hundreds of millions of dollars to Canada’s prescription drug bill. | read more...
April 24, 2003 If generic use in Quebec increased to the same level as in the rest of Canada Quebec would save $140 million in prescription drug costs A new report reinforces the position of the Canadian Generic Pharmaceutical Association
“Quebec could save $140 million in prescription drug costs if generic use in Quebec increased from 10% to 15% of overall drug revenues as is the case in the rest of Canada,” said Mr. Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA). | read more...
February 10, 2003 ratiopharm’s Jean-Guy Goulet Named Chair of Canadian Generic Pharmaceutical Association CGPA strengthens voice with new members: Pharmascience, Biovail Contract Research Division and PDi-Pharmaceuticals, Inc.
The Canadian Generic Pharmaceutical Association (CGPA) today announced the appointment of Jean-Guy Goulet, President and CEO of ratiopharm, as Chair of the Association. Allan Oberman, the President and CEO of Novopharm, takes over from Goulet as Vice-Chair, and Jack Kay, President of Apotex, becomes Past Chair, after serving more than a decade as the Association’s Chair. | read more...
January 29, 2003 Letter to Prime Minister Chrétien re: access to generic drugs
I am writing today to bring to your attention the latest move by U.S. President George W. Bush to help lower prescription drug costs by providing faster access to generic pharmaceuticals. | read more...
< back to news index		TOP